Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases
Huihui Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 74
Related Papers
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
Alkaloids from the Root of <i>Isatis indigotica</i>
|Journal of Natural Products|2012|167
Carthamin yellow improves cerebral ischemia‑reperfusion injury by attenuating inflammation and ferroptosis in rats
|International Journal of Molecular Medicine|2021|128
Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes
|Journal of Translational Medicine|2011|104